RS59654B1 - Amorfni lerkanidipin hidrohlorid - Google Patents
Amorfni lerkanidipin hidrohloridInfo
- Publication number
- RS59654B1 RS59654B1 RS20191591A RSP20191591A RS59654B1 RS 59654 B1 RS59654 B1 RS 59654B1 RS 20191591 A RS20191591 A RS 20191591A RS P20191591 A RSP20191591 A RS P20191591A RS 59654 B1 RS59654 B1 RS 59654B1
- Authority
- RS
- Serbia
- Prior art keywords
- lercanidipine hydrochloride
- amorphous lercanidipine
- amorphous
- hydrochloride
- lercanidipine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
- C07B63/04—Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65683605P | 2005-02-25 | 2005-02-25 | |
| PCT/EP2006/001782 WO2006089787A1 (en) | 2005-02-25 | 2006-02-24 | Amorphous lercanidipine hydrochloride |
| EP06723128.2A EP1856051B1 (en) | 2005-02-25 | 2006-02-24 | Amorphous lercanidipine hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS59654B1 true RS59654B1 (sr) | 2020-01-31 |
Family
ID=36585434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20191591A RS59654B1 (sr) | 2005-02-25 | 2006-02-24 | Amorfni lerkanidipin hidrohlorid |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US7820701B2 (sr) |
| EP (1) | EP1856051B1 (sr) |
| JP (1) | JP2008531515A (sr) |
| KR (1) | KR20070105979A (sr) |
| CN (1) | CN101124204A (sr) |
| AR (1) | AR052918A1 (sr) |
| AU (1) | AU2006218026B9 (sr) |
| BR (1) | BRPI0608138A2 (sr) |
| CA (1) | CA2598016A1 (sr) |
| CY (1) | CY1122429T1 (sr) |
| DK (1) | DK1856051T3 (sr) |
| EA (1) | EA014383B1 (sr) |
| ES (1) | ES2339213T3 (sr) |
| HR (1) | HRP20192302T1 (sr) |
| HU (1) | HUE046910T2 (sr) |
| IL (1) | IL184349A0 (sr) |
| LT (1) | LT1856051T (sr) |
| ME (1) | ME03659B (sr) |
| MX (1) | MX2007010093A (sr) |
| MY (1) | MY142129A (sr) |
| NO (1) | NO344559B1 (sr) |
| NZ (1) | NZ556667A (sr) |
| PE (1) | PE20061014A1 (sr) |
| PL (1) | PL1856051T3 (sr) |
| PT (1) | PT1856051T (sr) |
| RS (1) | RS59654B1 (sr) |
| SI (1) | SI1856051T1 (sr) |
| TW (1) | TW200640861A (sr) |
| UA (1) | UA90130C2 (sr) |
| UY (1) | UY29401A1 (sr) |
| WO (1) | WO2006089787A1 (sr) |
| ZA (1) | ZA200708127B (sr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050058982A1 (en) | 2002-07-26 | 2005-03-17 | Chiron Corporation | Modified small interfering RNA molecules and methods of use |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| KR20080048065A (ko) | 2005-09-16 | 2008-05-30 | 그렌마크 파머수티칼스 엘티디. | 다형 형태의 염산 레르카니디핀 및 이것의 제조방법 |
| PL2046745T3 (pl) * | 2006-08-04 | 2014-03-31 | Recordati Ireland Ltd | Sposób wytwarzania bezpostaciowego chlorowodorku lerkanidypiny |
| WO2008068777A2 (en) * | 2006-12-06 | 2008-06-12 | Torrent Pharmaceuticals Limited | Stable lercanidipine formulation |
| WO2008107797A2 (en) * | 2007-03-05 | 2008-09-12 | Actavis Group Ptc Ehf | Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate |
| AU2010247766B2 (en) * | 2009-05-12 | 2015-05-21 | Corcept Therapeutics, Inc. | Solid forms and process for preparing |
| DE102010005124A1 (de) * | 2010-01-19 | 2012-03-01 | Stada Arzneimittel Ag | Feste pharmazeutische Zusammensetzung umfassend Lercanidipin |
| EP2444394A1 (en) | 2010-10-21 | 2012-04-25 | Alembic Pharmaceuticals Limited | Process for the preparation of amorphous form of lercanidipine HCI |
| CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
| CN102531999B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 无定形盐酸乐卡地平及其制备方法 |
| CN102600146B (zh) * | 2012-04-11 | 2014-10-08 | 兆科药业（合肥）有限公司 | 一种盐酸乐卡地平和氯沙坦钾复方制剂及其制备方法 |
| US9951009B2 (en) * | 2013-08-29 | 2018-04-24 | Cadila Healthcare Limited | Polymorphic form of pyrrole derivative and intermediate thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
| US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
| US5696139A (en) * | 1995-05-12 | 1997-12-09 | Recordati S.A., Chemical And Pharmaceutical Company | Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure |
| IT1274480B (it) | 1995-05-12 | 1997-07-17 | Recordati Chem Pharm | Procedimento migliorato per la preparazione della lercanidipina cloridrato |
| US20030069285A1 (en) * | 2001-08-06 | 2003-04-10 | Recordati Ireland Limited | Novel solvate and crystalline forms of lercanidipine hydrochloride |
| ITMI20011727A1 (it) | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Solvati della lercanidipina cloridrato e nuove forme cristalline della lercanidipina cloridrato ottenute da essi |
| US6852737B2 (en) * | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
| ITMI20011726A1 (it) | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| US20030180355A1 (en) * | 2001-10-16 | 2003-09-25 | Amedeo Leonardi | Combination therapy for hypertension |
| JP4749660B2 (ja) * | 2002-10-16 | 2011-08-17 | 武田薬品工業株式会社 | 安定な固形製剤 |
| US20040147566A1 (en) * | 2002-10-16 | 2004-07-29 | Amedeo Leonardi | Lisinopril/lercanidipine combination therapy |
| US20040198789A1 (en) * | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
| TW200613275A (en) * | 2004-08-24 | 2006-05-01 | Recordati Ireland Ltd | Lercanidipine salts |
| TW200616681A (en) | 2004-10-05 | 2006-06-01 | Recordati Ireland Ltd | Lercanidipine capsules |
| KR100651212B1 (ko) | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
| AR052918A1 (es) | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| KR20080048065A (ko) | 2005-09-16 | 2008-05-30 | 그렌마크 파머수티칼스 엘티디. | 다형 형태의 염산 레르카니디핀 및 이것의 제조방법 |
| EP1963254A2 (en) | 2005-09-21 | 2008-09-03 | Torrent Pharmaceuticals Ltd | Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride |
| PL2046745T3 (pl) | 2006-08-04 | 2014-03-31 | Recordati Ireland Ltd | Sposób wytwarzania bezpostaciowego chlorowodorku lerkanidypiny |
-
2006
- 2006-02-22 AR ARP060100641A patent/AR052918A1/es not_active Application Discontinuation
- 2006-02-24 RS RS20191591A patent/RS59654B1/sr unknown
- 2006-02-24 AU AU2006218026A patent/AU2006218026B9/en not_active Ceased
- 2006-02-24 CN CNA2006800054950A patent/CN101124204A/zh active Pending
- 2006-02-24 EP EP06723128.2A patent/EP1856051B1/en not_active Revoked
- 2006-02-24 PT PT67231282T patent/PT1856051T/pt unknown
- 2006-02-24 HU HUE06723128A patent/HUE046910T2/hu unknown
- 2006-02-24 TW TW095106337A patent/TW200640861A/zh unknown
- 2006-02-24 KR KR1020077017758A patent/KR20070105979A/ko not_active Application Discontinuation
- 2006-02-24 EA EA200701687A patent/EA014383B1/ru unknown
- 2006-02-24 SI SI200632364T patent/SI1856051T1/sl unknown
- 2006-02-24 UY UY29401A patent/UY29401A1/es not_active Application Discontinuation
- 2006-02-24 CA CA002598016A patent/CA2598016A1/en not_active Abandoned
- 2006-02-24 LT LTEP06723128.2T patent/LT1856051T/lt unknown
- 2006-02-24 PL PL06723128T patent/PL1856051T3/pl unknown
- 2006-02-24 PE PE2006000224A patent/PE20061014A1/es active IP Right Grant
- 2006-02-24 JP JP2007556565A patent/JP2008531515A/ja active Pending
- 2006-02-24 UA UAA200709786A patent/UA90130C2/ru unknown
- 2006-02-24 MX MX2007010093A patent/MX2007010093A/es not_active Application Discontinuation
- 2006-02-24 WO PCT/EP2006/001782 patent/WO2006089787A1/en active Application Filing
- 2006-02-24 ME MEP-2019-352A patent/ME03659B/me unknown
- 2006-02-24 MY MYPI20060808A patent/MY142129A/en unknown
- 2006-02-24 ES ES06723128T patent/ES2339213T3/es active Active
- 2006-02-24 NZ NZ556667A patent/NZ556667A/en not_active IP Right Cessation
- 2006-02-24 DK DK06723128.2T patent/DK1856051T3/da active
- 2006-02-24 BR BRPI0608138-0A patent/BRPI0608138A2/pt not_active Application Discontinuation
- 2006-02-27 US US11/364,862 patent/US7820701B2/en active Active
-
2007
- 2007-07-02 IL IL184349A patent/IL184349A0/en active IP Right Grant
- 2007-09-21 ZA ZA200708127A patent/ZA200708127B/xx unknown
- 2007-09-25 NO NO20074874A patent/NO344559B1/no not_active IP Right Cessation
-
2019
- 2019-12-18 CY CY20191101332T patent/CY1122429T1/el unknown
- 2019-12-20 HR HRP20192302TT patent/HRP20192302T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL184349A0 (en) | Amorphous lercanidipine hydrochloride | |
| IL180905A0 (en) | Lercanidipine salts | |
| GB0525555D0 (en) | A device | |
| IL186172A0 (en) | Tool structure | |
| GB0519042D0 (en) | A device | |
| IL184185A0 (en) | Pure duloxetine hydrochloride | |
| GB0519259D0 (en) | A device | |
| PL1863803T3 (pl) | Podstawione piperydyny | |
| AU307950S (en) | A breathalyser | |
| IL185495A0 (en) | Amorphous cinacalcet hydrochloride and preparation thereof | |
| GB2429966B (en) | Shaft-ring gripper | |
| IL190552A0 (en) | A peptide-immunoglobulin-conjugate | |
| TWM290802U (en) | Pliers | |
| EP1864982A4 (en) | TRIAMINE DERIVATIVE | |
| GB2426998B (en) | A letterplate | |
| ZA200708126B (en) | Lercanidipine free base | |
| GB0516306D0 (en) | A device | |
| EP1951257A4 (en) | CRYSTALLINE FORMS | |
| GB2427415B (en) | A structure | |
| PT1916063E (pt) | Alicate | |
| GB0519506D0 (en) | A device | |
| GB0718028D0 (en) | A structure | |
| TWM284482U (en) | Tool holding structure | |
| ZA200606439B (en) | Prestressing device | |
| ZA200606886B (en) | Prestressing device |